These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 33087395)

  • 1. Covid-19 vaccine trial protocols released.
    Doshi P
    BMJ; 2020 Oct; 371():m4058. PubMed ID: 33087395
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 4. Sarah Gilbert: carving a path towards a COVID-19 vaccine.
    Lane R
    Lancet; 2020 Apr; 395(10232):1247. PubMed ID: 32305089
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review).
    Calina D; Docea AO; Petrakis D; Egorov AM; Ishmukhametov AA; Gabibov AG; Shtilman MI; Kostoff R; Carvalho F; Vinceti M; Spandidos DA; Tsatsakis A
    Int J Mol Med; 2020 Jul; 46(1):3-16. PubMed ID: 32377694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines: Setting Expectations Appropriately.
    Heininger U
    Pediatr Infect Dis J; 2020 Jul; 39(7):e123-e124. PubMed ID: 32427644
    [No Abstract]   [Full Text] [Related]  

  • 7. Keeping track of the SARS-CoV-2 vaccine pipeline.
    Parker EPK; Shrotri M; Kampmann B
    Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A timely update of global COVID-19 vaccine development.
    Klavinskis LS; Liu MA; Lu S
    Emerg Microbes Infect; 2020 Dec; 9(1):2379-2380. PubMed ID: 33059515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.
    Abu-Raya B; Gantt S; Sadarangani M
    CMAJ; 2020 Aug; 192(34):E982-E985. PubMed ID: 32646869
    [No Abstract]   [Full Text] [Related]  

  • 10. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 12. A vaccine is not too far for COVID-19.
    Patel SK; Pathak M; Tiwari R; Yatoo MI; Malik YS; Sah R; Rabaan AA; Sharun K; Dhama K; Bonilla-Aldana DK; Rodriguez-Morales AJ
    J Infect Dev Ctries; 2020 May; 14(5):450-453. PubMed ID: 32525830
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronavirus vaccines get a biotech boost.
    Dance A
    Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847
    [No Abstract]   [Full Text] [Related]  

  • 14. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Not Available].
    Nau JY
    Rev Med Suisse; 2020 Jun; 16(696):1176-1177. PubMed ID: 32496711
    [No Abstract]   [Full Text] [Related]  

  • 16. COVID-19 disrupts vaccine delivery.
    Nelson R
    Lancet Infect Dis; 2020 May; 20(5):546. PubMed ID: 32311326
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 18. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging vaccine delivery systems for COVID-19: Functionalised silica nanoparticles offer a potentially safe and effective alternative delivery system for DNA/RNA vaccines and may be useful in the hunt for a COVID-19 vaccine.
    Theobald N
    Drug Discov Today; 2020 Sep; 25(9):1556-1558. PubMed ID: 32592866
    [No Abstract]   [Full Text] [Related]  

  • 20. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
    Bull World Health Organ; 2020 Sep; 98(9):588-589. PubMed ID: 33012858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.